Physicists from the University of Sydney have devised a way to use diamonds to identify cancerous tumours before they become life threatening. Their reveal how a nano-scale, synthetic version of the precious gem can light up early-stage cancers in non-toxic, non-invasive Magnetic Resonance Imaging (MRI) scans. Targeting cancers with tailored chemicals is not new but scientists struggle to detect where these chemicals go since, short of a biopsy, there are few ways to see if a treatment has been taken-up by a cancer. Led by Professor David Reilly from the School of Physics, researchers from the University investigated how nanoscale diamonds could help identify cancers in their earliest stages. ‘We knew nano diamonds were of interest for delivering drugs during chemotherapy because they are largely non-toxic and non-reactive,’ says Professor Reilly. ‘We thought we could build on these non-toxic properties realizing that diamonds have magnetic characteristics enabling them to act as beacons in MRIs. We effectively turned a pharmaceutical problem into a physics problem.’ Professor Reilly’s team turned its attention to hyperpolarizing nano-diamonds, a process of aligning atoms inside a diamond so they create a signal detectable by an MRI scanner. ‘By attaching hyperpolarized diamonds to molecules targeting cancers the technique can allow tracking of the molecules’ movement in the body,’ says Ewa Rej, the paper’s lead author. ‘This is a great example of how quantum physics research tackles real-world problems, in this case opening the way for us to image and target cancers long before they become life-threatening,’ says Professor Reilly. The next stage of the team’s work involves working with medical researchers to test the new technology on animals. Also on the horizon is research using scorpion venom to target brain tumours with MRI scanning.
University of Sydneyhttp://tinyurl.com/h8qj2ah
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:30Scientists pave way for diamonds to trace early cancers
A teenage girl faced with sudden rapid heart deterioration, a man in the prime years of his life suffering from debilitating heart failure and a former NFL athlete crippled by end-stage heart failure were all successfully treated with a surgical approach pioneered by cardiac experts at University of California, San Diego School of Medicine. The work demonstrated significant benefits of implanting a left ventricular assist device (LVAD) in the right atrium to provide better blood flow through the lungs, giving complete biventricular circulatory support and fully replacing the heart’s function. An LVAD is a small mechanical pump traditionally placed inside the left ventricle – one of four chambers of the heart, located in the lower left of the organ – to help restore blood flow throughout the body. Unlike an artificial heart, the LVAD doesn’t replace the heart, but it can mean the difference between life and death for a person waiting for a transplant or suffering from advanced heart failure. ‘An LVAD relieves symptoms, such as being constantly tired or short of breath in patients with advanced heart disease,’ said Victor Pretorius, MBchB, lead author of the report and surgical director of cardiac transplant and mechanical circulatory support at UC San Diego Health. ‘The caveat is that the LVAD still depends on the right side of the patient’s heart to function optimally, and right ventricle failure is a common condition after an LVAD implantation, leaving some patients only partially treated. It is difficult to predict and increases mortality.’ Pretorius said biventricular support is required for up to 30 percent of LVAD recipients. Currently, no durable, long-term right ventricular assist device (RVAD) has received Food and Drug Administration approval, and placing an LVAD in the right ventricle, for which it was not designed, may jeopardize the device and heart function. ‘An alternative strategy would be to remove the heart completely and replace it with a total artificial heart, but this strategy does not allow for the failing heart to potentially recover, and there is the risk of the device malfunctioning,’ said Pretorius. ‘All three patients involved in the study were in desperate need of right-sided circulatory support. Our team placed an additional HeartWare HVAD, the smallest available LVAD, in the right atrium, the upper chamber of the heart, to provide right heart support.’ The right atrium is considered a more ideal chamber for placing a mechanical pump to support right-sided circulation. The absence of valve structures ensures unobstructed blood flow into the pump, and the location next to the right lung makes accommodation for the pump’s motor in the chest cavity more feasible. An LVAD is composed of a computer controller, a power pack and a reserve power pack that remain outside the body and are recharged at night. Patients with the innovative BiVAD approach have to carry a duplicate set for each pump, but Pretorius said this is generally well tolerated. Two of three patients in the study received successful heart transplants after receiving right-sided circulatory support, and the third patient remains in good condition with both LVADs still implanted.
University San Diego Healthhttp://tinyurl.com/zsjjwuh
Combining optical coherence tomography (OCT) with another advanced imaging technology may more accurately identify coronary artery plaques that are most likely to rupture and cause a heart attack. In a report, investigators from the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) describe the first use in patients of a catheter-based device utilizing both OCT and near-infrared autofluorescence (NIRAF) imaging.
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:292020-08-26 14:38:35Combining two imaging technologies may better identify dangerous coronary plaques
Older people are particularly at risk of water-loss dehydration – which is caused by not drinking enough fluid. It can lead to poor health outcomes such as disability and even death. The best test for diagnosing dehydration, known as a serum osmolality test, is expensive and not currently viable for wide-scale NHS screening. But new research published recently reveals how routine blood tests for sodium, potassium, urea and glucose could be used to screen for dehydration. By putting the results of these tests through an osmolarity equation’, health professionals can tell whether an older person is drinking enough fluid. Lead researcher Dr Lee Hooper from UEA’s Norwich Medical School said: ‘Around 20 per cent of older people living in residential care are dehydrated, and that figure rises to around 40 per cent among those admitted to hospital. ‘Older people often drink less than younger people for a variety of reasons. Loss of routine and fewer social contacts can reduce drinking. In some cases older people choose to drink less as getting to the toilet can be more difficult and take longer. It can be physically difficult to make, carry and drink a cup of tea when you get older – especially if you need a zimmer frame to walk about. And older people tend not to feel thirsty when they drink too little so their bodies don’t warn them to start drinking. ‘On top of all that – as our kidneys get older we are less able to concentrate our urine to preserve fluid, so the body’s ability to regulate its fluid balance slowly reduces. ‘Dehydration often goes unnoticed by carers, but it can lead to increased risk of hospital admission, urinary tract infections, disability and even death. ‘A serum osmolality test measures the freezing point of blood serum to show how concentrated a sample of blood is. People’s blood becomes more concentrated as they become dehydrated. ‘But it is an expensive and time consuming procedure – and clinical laboratories would not be able to handle routine screening. Simpler tests such as urine measurements, which appear to work well in children and young adults, do not work in older adults. ‘When our blood becomes more concentrated, as we become dehydrated, concentrations of serum sodium, potassium, urea and glucose rise. Many blood tests routinely measured in older people already check for all of these, and assess them independently. ‘We wanted to test whether results from routine tests for sodium, potassium, urea and glucose could be used together to accurately screen for dehydration by using a simple mathematical equation. ‘There are a number of different equations already being used, but they vary considerably from each other, and it wasn’t known which were most useful for elderly people. We wanted to find a universal equation which would be accurate for a broad range of elderly people including people with conditions such as diabetes.’ The research team studied 595 people over age 65 – including those who were healthy and lived independently, frail people living in residential care, and those in hospital. The group also spanned several European countries and took into account those with poor renal function and diabetes. They assessed the diagnostic accuracy of 39 different equations, and compared the results to directly measured serum osmolality. They found that an osmolarity equation described by Khajuria and Krahn had greatest universal accuracy – across healthy and frail older people, those in and out of hospital, with and without diabetes, with and without poor renal function, at all levels of dehydration and in men and women. Dr Hooper said: ‘We propose that clinical laboratories use this equation to report on hydration status of older people when reporting blood test results that include sodium, potassium, urea and glucose. We hope our findings will lead to pragmatic screening in older people to allow early identification of dehydration. This would help doctors, nurses and carers support older people to increase their fluid intake.’
University of East Angliahttp://tinyurl.com/hmefojk
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:032020-08-26 14:38:28Dehydration in older people could be accurately identified
Patients undergoing oncologic liver operations who participated in an enhanced recovery programme returned sooner to their normal life function and adjuvant cancer therapies than patients who were treated with a traditional approach to perioperative care, according to a new study. ‘What really matters is life function. Until now, we have been trying to add up a patient’s pain, nausea, and fatigue, but what we really needed to look at is how those symptoms actually impact a patient’s life function, because as it turns out, each patient experiences symptoms differently,’ said lead investigator Thomas A. Aloia, MD, FACS, associate professor, department of surgical oncology, The University of Texas MD Anderson Cancer Center, Houston. ‘We found that you could have very symptomatic people who were quite functional, and you could have mildly symptomatic people who were completely disabled.’ This single-centre study involved 118 patients undergoing both open and laparoscopic hepatectomy (surgical resection of the liver). In addition to traditional quality metrics like complications and length of stay, researchers collected data from a patient-reported outcomes tool called the MD Anderson Symptom Inventory (MDASI). All patients rated symptom severity and life interference using this validated survey, first preoperatively and again at every outpatient visit until 31 days after their operations. Typically, surgeons counsel patients that they are not going to feel better for a month after the operation, and that their full recovery will take about six to eight weeks. ‘Enhanced recovery,’ however, is a multicomponent perioperative care protocol created to speed patients’ recovery and return to normal life functions such as working and driving. This type of fast-track care plan involves preoperative patient education, fewer narcotic painkillers used during and after an operation (which have side effects that can lengthen the hospital stay), and a quicker return to eating and walking as soon as possible after the operation. In this study, 75 patients in the enhanced recovery group were compared with 43 patients in the traditional care group. All preoperative and postoperative care was the same for both groups, except the enhanced recovery part of it. The aim was to compare the difference between patients’ functional outcomes. The researchers found that patients treated in the enhanced recovery group were 2.6 times more likely to achieve their baseline functional status within 31 days than those who were treated with the traditional protocol. ‘The only independent factor that correlated to faster return to baseline functional status, both in terms of absolute value and short time to recovery, was being on an enhanced recovery protocol,’ Dr. Aloia said. ‘It wasn’t the size of the liver resection, the approach [laparoscopic versus open operation], or whether we used an epidural catheter for pain control or not.’ In this study, enhanced recovery patients reported lower postoperative pain scores and experienced fewer complications and decreased length of stay. The breakthrough from this study is that most enhanced recovery studies stop measuring their outcome at length of hospital stay, with the sole purpose of shortening the hospital visit. ‘At a cancer centre, length of stay is pretty low on our list of importance; our true metric of success is getting people after cancer surgery back to cancer therapy,’ Dr. Aloia said. The researchers also found that patients in the enhanced recovery group were more likely to return to chemotherapy (a measure researchers at this centre created and call Return to Intended Oncologic Therapy or RIOT), (95 percent vs. 87 percent), and at a shorter time interval compared with patients in the traditional group (44.7 days vs. 60.2 days). Because some of the patients were not indicated to receive further cancer treatment in this part of the analysis, these results aren’t statistically significant. Still, the researchers have no doubt that the trend is clear. ‘With this study, we may have got one step closer to a scientific definition of recovery that could be used in other disease sites,’ Dr. Aloia said. ‘As enhanced recovery strategies evolve we may now have a tool to compare one approach with another to find out which one is better.’
American College of Surgeonshttp://tinyurl.com/h9yz499
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:032020-08-26 14:38:27New care approach to liver operations speeds patient recovery
Market opportunities in the women’s healthcare imaging and nutrition segment are ripe, especially in developing nations where awareness of preventive medicine is rising. Issues afflicting women include breast cancer, urinary tract infections, anemia, cardiovascular diseases and osteoporosis. In response, the healthcare industry is progressively employing early diagnosis through screening and prescribing preventive solutions in the form of nutrients supplemented through diet. Analysis from Frost & Sullivan, Technology Trends in Women’s Health, explores developments in the fields of health nutrients and health imaging for women. Manufacturers are trying to customize nutrients according to a woman’s lifecycle since the needs of prenatal, postnatal and menopausal women are different. The main health nutrients women consume are calcium, iron and vitamin D. In imaging, technological advancements will focus on platforms that:
Reduce the ionizing radiation dose;
Provide physiological image data to highlight cellular activities indicative of cancer, rather than only using anatomical data;
Allow image acquisition and viewing in more than two spatial dimensions;
‘Customized innovation is essential in the women’s health sector,’ said Technical Insights Industry Analyst Darshana De. ‘In addition to age-related nutritional requirements, a woman’s health needs vary according to geographic and consumer preferences. Demand is high for natural supplements, strong scientific evidence of health claims and minimal side effects. For instance, the constipation and gastrointestinal symptoms caused by available calcium tablets are driving innovations within the industry to provide a more natural form of calcium.’ In the women’s imaging segment, digitization is a sweeping trend. Hospitals and screening centres worldwide are digitizing systems to optimize workflows and enhance image clarity. Government initiatives are pushing several advances. A U.S. federal bill (HR 3102) mandates breast density reporting on a national level to generate interest in newer technologies improving image screening accuracy. ‘Tomosynthesis will become the primary screening modality; it offers the ability to view slices of the breast to better differentiate actual lesions from areas of overlapping dense tissue,’ noted De. Similarly, government-initiated screening programs, designed to diagnose osteoporosis in developed countries, are encouraging bone density scans and boosting the sales of densitometry systems. However, the high initial investment for scanning systems and reimbursement issues can bring challenges to the market.
Frost & Sullivanhttp://tinyurl.com/jkgj7xz
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:032020-08-26 14:38:27Nutrients and imaging are evolving to protect women against age-related disorders
A study that used fake patients to assess the performance of direct-to-consumer teledermatology websites suggests that incorrect diagnoses were made, treatment recommendations sometimes contradicted guidelines, and prescriptions frequently lacked disclosure about possible adverse effects and pregnancy risks, according to an article. In the US, direct-to-consumer teledermatology (DTC) is rapidly expanding and large DTC services are contracting with major health plans to provide telecare. However, relatively little is known about the quality of these services. Jack S. Resneck, Jr., M.D., of the University of California, San Francisco, and co-authors used study personnel posing as patients to submit six dermatologic cases with photographs, including neoplastic, inflammatory and infectious conditions, to regional and national DTC telemedicine websites and smartphone apps offering services to California residents. The photographs were mostly obtained from publicly available online image search engines. Study patients claimed to be uninsured and paid fees using Visa gift debit cards; no study personnel provided any false government-issued identification cards or numbers. The authors received responses from 16 DTC websites for 62 clinical encounters over about a month from February to March 2016. The authors report: None of the websites asked for identification or raised concern about pseudonym use or falsified photographs. During 68 percent of encounters, patients were assigned a clinician without any choice; 26 percent disclosed information about clinician licensure; and some used internationally based physicians without California licenses; 23 percent collected the name of an existing primary care physician and 10 percent offered to send records. A diagnosis or a likely diagnosis was given in 77 percent of cases; prescriptions were ordered in 65 percent of these cases; and relevant adverse effects or pregnancy risks were disclosed in a minority of those. The websites made several correct diagnoses in cases where photographs alone were adequate but when additional history was needed they often failed to ask simple, relevant questions. Major diagnoses were missed including secondary syphilis, eczema herpeticum, gram-negative folliculitis and polycystic ovarian syndrome. Treatments prescribed were sometimes at odds with guidelines. A significant limitation to this study is that the authors were unable to assess whether clinicians seeing these patients in traditional in-person encounters would have performed any better. The authors offer a series of recommended practices for DTC telemedicine websites, including obtaining proof of patient identity, collecting relevant medical history, seeking laboratory tests when an in-person physician would have relied on that information, having relationships with local physicians in all the areas where they treat patients, and creating quality assurance programmes.
JAMAhttp://tinyurl.com/hctx7t5
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:032020-08-26 14:38:27Study assesses performance of direct-to-consumer teledermatology services
About a quarter of healthcare providers said their virtual care programmes – telemedicine and telehealth – are financially sustainable and are improving efficiency, patient volumes and loyalty by filling gaps in medical specialties or helping chronically ill patients, according to a poll conducted by KPMG LLP, the U.S. audit, tax and advisory firm. Telehealth, which uses technology to connect clinicians with patients, is gaining credence in urgent care settings from mobile devices, ‘primary care plus’ from retail clinics or for psychiatric assessments in an emergency department. Telemedicine – clinician-to-clinician consults – has a long history in radiology and for remote, underserved patient populations where specialists are needed for their clinical expertise, but it is gaining greater use. For example, telemedicine is used for neurology consults for stroke patients and also for referring nursing home patients to hospitals if they need more acute care. ‘Healthcare providers need to think of virtual care as a means to improve patient access and provider efficiency, especially as value-based contracts and other reimbursement incentives gain a greater share of revenue, while meeting patient care needs by filling gaps for key medical specialties,’ said Dr. Richard Bakalar, managing director at KPMG and a member of the firm’s Global Healthcare Center of Excellence. ‘Telehealth is rapidly evolving beyond urgent care and is increasingly used for follow up visits and helping chronically ill patients connect with their doctor online. Health plans and government payers are seeing the value from the technology and enhancing reimbursement for virtual care.’ Yet, approximately 35 percent of respondents in the poll said they have not yet started a programme incorporating virtual care, and the remaining 40 percent are in early stages.
KPMG’s poll found that the biggest drivers for expediting adoption of virtual care were:
Increase patient volumes and loyalty (29 percent)
Care coordination of high risk patients (17 percent)
Reduce costs for access to medical specialists (17 percent)
Meaningful use and payer incentives for adoption (13 percent)
Patient requests/consumer demand (13 percent).
Implementing a virtual care programme is not without challenges, however. Healthcare providers cited several, including:
Too many other technological priorities (19 percent)
Maintaining a sustainable business model (18 percent)
Organizational readiness to implement new services/technology (18 percent)
Regulatory compliance and risk concerns (15 percent).
KPMG LLPhttp://tinyurl.com/hlgwoyk
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:032020-08-26 14:38:27A quarter of USA healthcare providers make strides in telemedicine/telehealth:
‘OB Nest’: Just the name may bring warm feelings to parents and prospective parents. However, at Mayo Clinic, it’s much more than a name. It’s a new way that Mayo Clinic is providing prenatal care. And, families say they are thrilled with the process. Current prenatal care for a pregnancy consists of 12-14 visits with an obstetrician. However, often these visits are just brief check-ins to make sure a pregnancy is progressing well. Previous research has looked at ways to give providers more time for high-risk patients, and save time and office visits for women with low-risk pregnancies. While these studies have shown that fewer visits are safe, patients reported less satisfaction overall. Seeking to identify ways to improve patient experience and perceived value, Mayo Clinic researchers decided to test a new way of providing prenatal care, dubbed ‘OB Nest.’ With the changes to the care experience provided within OB Nest, the researchers found that not only did patient satisfaction improve, but also this improved satisfaction came with fewer office visits. ‘Traditionally, pregnancy is treated as a sickness,’ says Yvonne Butler Tobah, M.D., a Mayo Clinic obstetrician and lead author of this study. ‘We wanted our care to reflect the normal, life-bringing event that it is, and [we] looked for a way to transform prenatal care into a wellness, patient-oriented experience.’ The Department of Obstetrics and Gynecology, in collaboration with the Center for Innovation, worked with patients and staff to collect and prioritize ideas to improve the way pregnant women and their families experience prenatal care. Along with the department, the Care Experience Program, which is part of the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Healthcare Delivery, took this information and these ideas and designed evidence-based practice improvements for prenatal care. OB Nest study participants – all of whom were experiencing low-risk pregnancies – entered the programme with a specific nurse identified as their lead contact. They received eight scheduled office visits (More were optional.) and home monitoring equipment for fetal heart rate and maternal blood pressure. In addition, they could take part in an online care community with other OB Nest participants and nurses from the OB Nest care team. ‘My schedule is very hectic,’ says Seri Carney, M.D., a mom who participated in the OB Nest study during pregnancy with her second child. ‘It was really nice to only have to go in for my appointments every other month. My husband and I didn’t have to worry as often about arranging our work schedules for the appointments.’ ‘We could listen to the heartbeat whenever we wanted,’ says Dr. Carney. ‘Our daughter was 4 at the time, and doing it at home meant that she could get involved, too. That was really fun. It also felt like it made me more aware of the movements and heartbeat of my baby.’ In her third trimester, when Dr. Carney noticed her baby’s heartbeat was a little low, she was able to email her care team. They reacted right away and got Carney in for a stress test. All was fine, and within a few weeks, she and her family welcomed baby Luisa Jane. The OB Nest research project is part of Mayo Clinic’s healthcare delivery research efforts, and aligns with the Institute for Healthcare Improvement Triple Aim. ‘This fulfills the holy grail of what patients expect today,’ says Abimbola Famuyide, M.B.B.S., chair of the Department of Obstetrics and Gynecology, and study principal investigator. ‘How can we continue to improve patient experience and clinical outcomes, while, at the same time, keep costs down?’ ‘Improving the patient experience, in the case of OB Nest, includes empowering expectant women to truly engage in, and take control of, their care,’ says Dr. Famuyide. He and his team learned that having one nurse as the centre point for each woman’s care and concerns provided them the comfort of easy connection. Concurrently, fewer office visits saved healthcare provider resources, while reducing patient burden. This practice transforming research is leading to permanent changes in the way women receive prenatal care across Mayo Clinic. It is part of the goal of the Mayo Model of Community Care, to deliver wellness-focused, high-value healthcare – improving access, convenience and patient satisfaction, while lowering costs.
Mayo Clinichttp://tinyurl.com/jsjgz2t
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:38:032020-08-26 14:38:27OB Nest’: a novel approach to prenatal care
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.